Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Annette Chalker"'
Autor:
Steven Duffy, Manuela A. Joore, Nigel Armstrong, Annette Chalker, Sabine Grimm, Robert Wolff, Isabel Syndikus, Mickaël Hiligsmann, Willem J.A. Witlox, Jos Kleijnen, Charlotte Ahmadu, Ben F. M. Wijnen, Steve Ryder
Publikováno v:
Pharmacoeconomics. 40(5):509-518
The National Institute for Health and Care Excellence (NICE) invited the manufacturer (Kyowa Kirin) of mogamulizumab (Poteligeo(R)), as part of the single technology appraisal process, to submit evidence for its clinical and cost-effectiveness for pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc1ab53ca166964105141105c17b0b0b
https://doi.org/10.1007/s40273-021-01098-3
https://doi.org/10.1007/s40273-021-01098-3
Autor:
Robert Wolff, Antoinette van Asselt, Sajad Emamipour, Simon van der Pol, Maarten Postma, Annette Chalker, Pawel Posadzki, Charlotte Ahmadu, Nigel Armstrong, Sean Harrison, Shelley de Kock, Jos Kleijnen
Publikováno v:
University of Groningen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::23e58eecb908379de1413f5122c7b7e3
https://research.rug.nl/en/publications/e733e1d7-109f-4216-a4ee-c1c677c5655f
https://research.rug.nl/en/publications/e733e1d7-109f-4216-a4ee-c1c677c5655f
Autor:
Manuela A. Joore, Jos Kleijnen, Alastair K Denniston, Svenja Petersohn, Vanesa Huertas Carrera, Gill Worthy, Annette Chalker, Willem J.A. Witlox, Caro Noake, Nigel Armstrong, Xavier Pouwels, Heike Raatz, Rob Riemsma
Publikováno v:
Pharmacoeconomics, 38(6), 649-651. Adis International Ltd
PharmacoEconomics, 38, 649-651. Adis International Ltd
PharmacoEconomics, 38, 649-651. Adis International Ltd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b5e87c9dc8dabcd80a101a522aa1ad1
https://doi.org/10.1007/s40273-020-00900-y
https://doi.org/10.1007/s40273-020-00900-y
Autor:
Vanesa Huertas Carrera, Svenja Petersohn, Gill Worthy, Heike Raatz, Alastair K Denniston, Annette Chalker, Manuela A. Joore, Xavier Pouwels, Rob Riemsma, Caro Noake, Nigel Armstrong, Jos Kleijnen, Willem J.A. Witlox, Dhwani Shah
Publikováno v:
Pharmacoeconomics
The National Institute for Health and Care Excellence (NICE) invited Alimera Sciences, the company manufacturing fluocinolone acetonide intravitreal implant (FAc) 0.19 mg (tradename ILUVIEN), to submit evidence on the clinical and cost-effectiveness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c28282025c9a856b1360e9c0e2ca650
https://doi.org/10.1007/s40273-019-00851-z
https://doi.org/10.1007/s40273-019-00851-z
Autor:
Sabine E. Grimm, Willem Witlox, Robert Wolff, Annette Chalker, Mickael Hiligsmann, Ben Wijnen, Charlotte Ahmadu, Steve Ryder, Nigel Armstrong, Steven Duffy, Isabel Syndikus, Jos Kleijnen, Manuela A. Joore
Publikováno v:
Pharmacoeconomics. 40(5):575-575
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc59899cfa94940213344c6c9ed4bb77
https://doi.org/10.1007/s40273-022-01144-8
https://doi.org/10.1007/s40273-022-01144-8
Autor:
Willem J.A. Witlox, Robert Wolff, Nigel Armstrong, Jos Kleijnen, Titas Buksnys, Antoinette D I van Asselt, Annette Chalker, Gill Worthy, Lisa Stirk, Manuela A. Joore, Sabine Grimm
Publikováno v:
Pharmacoeconomics
As part of the Single Technology Appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited the manufacturer (AstraZeneca) of durvalumab (IMFINZI(TM)) to submit evidence for the clinical and cost effectiveness of du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7182e13e63855a1c6eb4c79eb80ed06f
https://pubmed.ncbi.nlm.nih.gov/31814080
https://pubmed.ncbi.nlm.nih.gov/31814080